AAAAAA
Results: 101-125/191
Authors:
ARLEN M
TSANG A
MARCHILDON G
WANG T
SCHERRER J
Citation: M. Arlen et al., IMMUNODIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF COLON-CANCER USING PROTEIN-DERIVED MONOCLONAL-ANTIBODY-31.1, Journal of tumor marker oncology, 12(1), 1997, pp. 5-11
Authors:
ZHANG JR
FAN ST
YU WC
Citation: Jr. Zhang et al., GASTRIC-CANCER ASSOCIATED GLYCOPROTEIN WITH BISECTION GLCNAC STRUCTURE, Journal of tumor marker oncology, 12(1), 1997, pp. 13-19
Authors:
NAIDU R
YADAV M
KUTTY MK
Citation: R. Naidu et al., IMMUNOHISTOCHEMICALLY DETECTED EXPRESSION OF BREAST TUMOR-ASSOCIATED GLYCOPROTEIN (323 A3) IN BREAST-CANCER/, Journal of tumor marker oncology, 12(1), 1997, pp. 21-27
Authors:
MOR C
GARIBOLDI A
BISSI O
CONCAS D
DIMATTIA D
GAJANI MR
GILARDONI E
LIVERANI A
MANCINI S
SANTI C
BARTORELLI A
Citation: C. Mor et al., ON THE COMPASSIONATE USE OF UK101 IN METASTATIC CANCER, Journal of tumor marker oncology, 12(1), 1997, pp. 29-37
Authors:
CIOFFI M
GAZZERRO P
FRATTA M
DIFINIZIO B
TUCCI A
VIETRI MT
DELUCIA D
MOLINARI AM
PUCA GA
Citation: M. Cioffi et al., TUMOR-ASSOCIATED ANTIGEN CA242 IN PANCREATIC-CANCER - COMPARISON WITHESTABLISHED MARKER SUCH AS CA-19-9, Journal of tumor marker oncology, 12(1), 1997, pp. 39-44
Authors:
MEGGIATO T
FERRARA C
TESSARI G
PLEBANI M
DEPAOLI M
CORSINI A
DELFAVERO G
Citation: T. Meggiato et al., NEURAL CELL-ADHESION MOLECULE (NCAM) IN PANCREATIC-CANCER - A MARKER OF PROGRESSION, Journal of tumor marker oncology, 12(1), 1997, pp. 45-51
Authors:
VANSON H
Citation: H. Vanson, ON THE MEASUREMENT OF TUMOR-MARKERS IN VIETNAM, Journal of tumor marker oncology, 12(1), 1997, pp. 53-59
Authors:
JORGENSEN L
Citation: L. Jorgensen, FOREWORD, Journal of tumor marker oncology, 11(4), 1996, pp. 5-5
Authors:
JORGENSEN LGM
OSTERLIND K
GOMM SA
HERNANDEZ JR
JOHNSON PWM
LOBER J
SPLINTER TAW
SZTURMOWICZ M
Citation: Lgm. Jorgensen et al., TUMOR-MARKER AIDED DISCRIMINATION BETWEEN DISEASE STAGES IN SMALL-CELL LUNG-CANCER (SCLC), Journal of tumor marker oncology, 11(4), 1996, pp. 7-14
Authors:
JORGENSEN LGM
BOTTCHER SG
CHRISTENSEN ES
LUNDBYECHRISTENSEN S
WINKEL P
Citation: Lgm. Jorgensen et al., MONITORING SMALL-CELL LUNG-CANCER (SCLC) BY SERUM NEURON-SPECIFIC ENOLASE (S-NSE) ANALYSES USING DYNAMIC LINEAR-MODELS, Journal of tumor marker oncology, 11(4), 1996, pp. 15-21
Authors:
SZTURMOWICZ M
SAKOWICZ A
REMISZEWSKI P
SZOPINSKI J
WASOWSKA H
ZYCH J
ROWINSKAZAKRZEWSKA E
Citation: M. Szturmowicz et al., THE ROLE OF SERUM NEURON-SPECIFIC ENOLASE MONITORING FOR EVALUATION OF TREATMENT RESULTS AND PROGNOSIS IN SMALL-CELL LUNG-CANCER PATIENTS, Journal of tumor marker oncology, 11(4), 1996, pp. 23-28
Authors:
PRENTO P
JORGENSEN LGM
Citation: P. Prento et Lgm. Jorgensen, APPLICABILITY OF DIRECT OR COUPLED ENOLASE KINETIC ASSAYS IN CLINICALBIOCHEMISTRY, Journal of tumor marker oncology, 11(4), 1996, pp. 29-34
Authors:
MOMSEN G
JORGENSEN LGM
Citation: G. Momsen et Lgm. Jorgensen, A MULTIVARIATE CONTROL-SYSTEM FOR QUALITY-CONTROL OF IMMUNOFLUOROMETRIC ASSAY FOR SERUM NEURON-SPECIFIC ENOLASE (S-NSE), Journal of tumor marker oncology, 11(4), 1996, pp. 35-48
Authors:
JOHNSON PWM
MACLENNAN KA
SWINBANK K
CARTER R
SELBY PJ
Citation: Pwm. Johnson et al., CHROMOGRANIN - A EXPRESSION FOR THE DETECTION OF CIRCULATING SMALL-CELL LUNG-CANCER - IMMUNOCYTOCHEMISTRY IS MORE SENSITIVE THAN REVERSE-TRANSCRIPTASE PCR, Journal of tumor marker oncology, 11(4), 1996, pp. 49-53
Authors:
DNISTRIAN AM
SCHWARTZ MK
GREENBERG EJ
SMITH CA
SCHWARTZ DC
MAIMONIS P
Citation: Am. Dnistrian et al., EVALUATION OF A BREAST-CANCER ANTIGEN ASSAYED ON THE CIBA-CORNING ACS180(R) AUTOMATED CHEMILUMINESCENCE SYSTEM/, Journal of tumor marker oncology, 11(3), 1996, pp. 5-10
Authors:
JORGENSEN LGM
PRENTO P
JENSEN G
Citation: Lgm. Jorgensen et al., NEURON-SPECIFIC ENOLASE (NSE) AND THE NEUROENDOCRINE AND CYTOGENETIC CHANGES OF SMALL LUNG-CANCER (SCLC) CELL-LINES DURING CHEMOTHERAPY, Journal of tumor marker oncology, 11(3), 1996, pp. 11-22
Authors:
HALIM AB
ELAHMADY O
EISSA S
BADARY OA
AGHA A
OEHR P
Citation: Ab. Halim et al., DOES TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN (TPS) RELATE TO TISSUE POLYPEPTIDE ANTIGEN (TPA) IN EHRLICH ASCITES-CARCINOMA (EAC)-BEARING MICE, Journal of tumor marker oncology, 11(3), 1996, pp. 23-28
Authors:
YASASEVER V
KARALOGLU D
KIZIR A
CAMLICA H
DALAY N
Citation: V. Yasasever et al., EVALUATION OF SERUM TUMOR-MARKERS IN GASTROINTESTINAL-TRACT TUMORS, Journal of tumor marker oncology, 11(3), 1996, pp. 29-33
Authors:
ROISMAN I
LIFSHITZ I
BITTERMAN A
COLEMAN R
TOLEDANO H
BARZILAY A
DURST AL
REZNICK AZ
Citation: I. Roisman et al., IMMUNOSTAINING AND TUMOR-MARKERS IN VARIOUS NEOPLASMS, Journal of tumor marker oncology, 11(3), 1996, pp. 35-53
Authors:
BIRKMAYER GD
Citation: Gd. Birkmayer, RESUME OF THE 13TH INTERNATIONAL-CONFERENCE ON HUMAN TUMOR-MARKERS SINGAPORE, JUNE 16-19, 1996, Journal of tumor marker oncology, 11(3), 1996, pp. 61-64
Citation: 13TH INTERNATIONAL-CONFERENCE ON HUMAN TUMOR-MARKERS - JUNE 15-19, 1996 SINGAPORE - OPENING LECTURE - SUNDAY, JUNE 16, 1996 - ABSTRACTS, Journal of tumor marker oncology, 11(2), 1996, pp. 34
Authors:
ROISMAN I
BARAK V
REZNICK A
BITTERMAN A
PERETZ T
DURST AL
Citation: I. Roisman et al., BREAST-CANCER - SCREENING, DETECTION, TUMOR-MARKERS AND SURGICAL-MANAGEMENT, Journal of tumor marker oncology, 11(2), 1996, pp. 131-155
Authors:
HEINZE T
PRESSEL C
MINGUILLION C
LICHTENEGGER W
Citation: T. Heinze et al., MAMMARY SERUM ANTIGEN (MSA), CA-15-3 AND CEA IN PREOPERATIVE SERA OF BREAST-CANCER PATIENTS AND CORRELATIONS WITH PROGNOSTIC FACTORS, Journal of tumor marker oncology, 11(2), 1996, pp. 156-159
Authors:
GIANNI W
VETTA F
LATO PFA
BUCHER L
GAZZANIGA P
BRESSAN AM
BIRARELLI P
DEMASSIMO M
CACCIAFESTA M
PICCOLI M
MARIGLIANO V
Citation: W. Gianni et al., LOW NK ACTIVITY AS UNFAVORABLE PROGNOSTIC MARKER IN ELDERLY PATIENTS WITH CANCER, Journal of tumor marker oncology, 11(2), 1996, pp. 161-163
Authors:
LYNCH HT
Citation: Ht. Lynch, UNTITLED - PREFACE, Journal of tumor marker oncology, 11(1), 1996, pp. 5-8